Navigation Links
OPC Connectivity Between TruBio Software and Nova FLEX Analyzers
Date:3/5/2009

SANTA CLARA, Calif., March 5 /PRNewswire/ -- Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for bioprocess applications, and Nova Biomedical, Waltham, MA, a world leader in biotechnology process monitoring announced the release of a TruBio(TM) plug-in for OPC connectivity between TruBio control software and Nova FLEX(TM) analyzers. OPC is the de facto standard for data exchange between process control systems and different hardware platforms.

OPC-based communication between a FLEX and TruBio reduces errors or time delays of manual sampling, and provides automated reporting of results. More sophisticated process control strategies can be implemented, process parameters can be adjusted without human intervention, and, when process alarm conditions occur, off-site personnel can be alerted and/or automatic corrective action be taken. Additionally, all off-line FLEX data can be directly consolidated into the TruBio/DeltaV historian, or used in automated batch report generation for electronic records.

Basil Zimmo, Vice President of Software at Finesse, stated, "The Nova FLEX-TruBio plug-in will reduce operating costs: printouts of standalone analyzer results will no longer have to be manually attached or tracked. Furthermore, this product will improve bioprocess quality and yield: programming a Nova FLEX to automatically standardize an in-situ probe or using FLEX cell viability data in real-time algorithms will increase the accuracy and repeatability of control."

"By redefining the standard associated with offline data to include complete integration and the value of those data as they are applied to the bioprocess automatically, Nova and Finesse continue to provide the cutting edge technology required to bring the biotechnology industry into a new era of effectiveness and profitability, thereby allowing our customers real-time benefits that, until now, were impossible," said a Nova Biomedical spokesperson.

About Finesse Solutions, LLC

California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries. For more information, please visit us at www.finesse.com.

About Nova Biomedical

Nova Biomedical is committed to continue its technology leadership with advanced products that provide better, faster diagnostic information. We continue to innovate biotechnology instruments that allow faster, more economical development of drugs and other therapeutic products.


'/>"/>
SOURCE Finesse Solutions, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Finesse Solutions, LLC Announces OPC Connectivity With Nova BioProfile 400
2. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
3. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
4. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
5. PCAS : Tighter Links Between PCAS and Proteus
6. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
7. ES Vascular Receives CE Mark for its First Aortic Stapler for End-to-End Anastomosis Between Synthetic Grafts and Aorta During Open Repair of Aortic Aneurysmal and Occlusive Disease
8. New Fragment-based Drug Discovery Platform Announced Between IOTA Pharmaceuticals Ltd, Cambridge (UK), and Beactica AB, Uppsala (Sweden)
9. DolmatConnell & Partners 2008 Studies of CEO and CFO Compensation in the 100 Largest High Technology and Life Science Companies Show Dramatically Improving Link Between Pay and Performance
10. IDF Urges Healthcare Providers to Address the Relationship Between Type 2 Diabetes and Sleep Apnea
11. Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... ... 23, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... Laboratory, has joined STACS DNA as a Field Application Specialist. , “I am ... and COO of STACS DNA. “In further expanding our capacity as a scientific integrator, ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):